Literature DB >> 34730280

New mint on the block - Fresh hope for IBS treatment?

Radislav Nakov1, Henriette Heinrich2,3.   

Abstract

Entities:  

Keywords:  IBS; Irritable bowel syndrome; constipation; gastroenterology; motility

Mesh：

Substances：

Year:  2021        PMID： 34730280      PMCID： PMC8598954          DOI： 10.1002/ueg2.12166

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  10 in total

1.  Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.

Authors:  Christopher J Black; Yuhong Yuan; Christian P Selinger; Michael Camilleri; Eamonn M M Quigley; Paul Moayyedi; Alexander C Ford
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-16

2.  A novel role for TRPM8 in visceral afferent function.

Authors:  Andrea M Harrington; Patrick A Hughes; Christopher M Martin; Jing Yang; Joel Castro; Nicole J Isaacs; Ashley L Blackshaw; Stuart M Brierley
Journal:  Pain       Date:  2011-04-13       Impact factor: 6.961

3.  Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.

Authors:  Zsa Zsa R M Weerts; Ad A M Masclee; Ben J M Witteman; Cees H M Clemens; Bjorn Winkens; Jacobus R B J Brouwers; Henderik W Frijlink; Jean W M Muris; Niek J De Wit; Brigitte A B Essers; Jan Tack; Johanna T W Snijkers; Andrea M H Bours; Annieke S de Ruiter-van der Ploeg; Daisy M A E Jonkers; Daniel Keszthelyi
Journal:  Gastroenterology       Date:  2019-08-27       Impact factor: 22.682

4.  Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.

Authors:  M E Flacco; L Manzoli; R De Giorgio; A Gasbarrini; A Cicchetti; F Bravi; M Altini; G P Caio; F Ursini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-04       Impact factor: 3.507

Review 5.  Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.

Authors:  B P Chumpitazi; G L Kearns; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2018-01-26       Impact factor: 8.171

Review 6.  Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Authors:  Paul Moayyedi; Fermín Mearin; Fernando Azpiroz; Viola Andresen; Giovanni Barbara; Maura Corsetti; Anton Emmanuel; A Pali S Hungin; Peter Layer; Vincenzo Stanghellini; Peter Whorwell; Frank Zerbib; Jan Tack
Journal:  United European Gastroenterol J       Date:  2017-09-28       Impact factor: 4.623

7.  A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.

Authors:  Zsa Zsa R M Weerts; Brigitte A B Essers; Daisy M A E Jonkers; Jeresa I A Willems; Deborah J P A Janssen; Ben J M Witteman; Cees H M Clemens; Audrey Westendorp; Ad A M Masclee; Daniel Keszthelyi
Journal:  United European Gastroenterol J       Date:  2021-09-01       Impact factor: 4.623

8.  Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.

Authors:  Hans Törnblom; Richard Goosey; Gwen Wiseman; Stephen Baker; Anton Emmanuel
Journal:  United European Gastroenterol J       Date:  2018-07-09       Impact factor: 4.623

9.  Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.

Authors:  Judy Nee; Sarah Ballou; John M Kelley; Ted J Kaptchuk; William Hirsch; Jesse Katon; Vivian Cheng; Vikram Rangan; Anthony Lembo; Johanna Iturrino
Journal:  Am J Gastroenterol       Date:  2021-11-01       Impact factor: 10.864

10.  Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis.

Authors:  Eric D Shah; Jessica K Salwen-Deremer; Peter R Gibson; Jane G Muir; Shanti Eswaran; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-01       Impact factor: 11.382
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.